Quarterly report pursuant to Section 13 or 15(d)

Stock options and warrants (Tables)

v2.4.0.8
Stock options and warrants (Tables)
9 Months Ended
Sep. 30, 2014
Stock options and warrants [Abstract]  
Schedule of Recognized Stock-based Compensation

 

   

Three Months Ended

   

Nine Months Ended

 
   

2014

   

2013

   

2014

   

2013

 
                         

Stock options to employees and directors

  $ 213,988     $ 332,150     $ 943,061     $ 1,226,304  

Stock options to consultants for APPY1 activities

    86       100       425       1,293  
                                 

    Total stock-based compensation

  $ 214,074     $ 332,250     $ 943,486     $ 1,227,597  
Schedule of the Income Statement Allocation of Stock-based Compensation
   

Three Months Ended

   

Nine Months Ended

 
   

2014

   

2013

   

2014

   

2013

 
                                 

Selling, general and administrative expenses

  $ 201,543     301,888     889,888     $ 1,111,623  

Research and development expenses

    12,531       30,362       53,598       115,974  
                                 

    Total stock-based compensation

  $ 214,074     $ 332,250     $ 943,486     $ 1,227,597  
Schedule of Fair Value Assumptions Used to Estimate Stock-based Compensation
   

2014

 

2013

 
           

Dividend yield

    0 %     0 %

Expected price volatility

    96-126 %     127-128 %

Risk free interest rate

    1.52-1.74 %     0.65-0.76 %

Expected term

    5 years     5 years  
Summary of Stock Incentive Plan Activity

 

   

Shares
Underlying
Options

   

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual

Term (Years)

   

Aggregate

Intrinsic

Value

 
                         

Outstanding at January 1, 2014

    1,218,265     $ 8.70              

     Granted

    727,100       2.29              

     Exercised

    (39,079     2.09              

     Forfeited

    (41,561     30.01              
                             

Outstanding at September 30, 2014

    1,864,725     $ 5.87       8.4     $ -  
                                 

Exercisable at September 30, 2014

    1,428,956     $ 6.96       8.1     $ -  
Schedule of Nonvested Share Activity

 

Nonvested Shares

 

Nonvested
Shares
Underlying
Options

   

Weighted

Average

Exercise

Price

   

Weighted

Average

Grant Date

Fair Value

 
                   

Nonvested at January 1, 2014

    200,446     $ 2.95     $ 2.48  

     Granted

    727,100       2.29       1.89  

     Vested

        (486,727 )     2.57       2.15  

     Forfeited

    (5,050 )     2.15       1.77  
                         

Nonvested at September 30, 2014

    435,769     $ 2.27     $ 1.86  
Schedule of Nonqualified Award Activity

 

   

Shares
Underlying
Options / Warrants

   

Weighted

Average

Exercise

Price

 

Weighted

Average

Remaining

Contractual

Term (Years)

   

Aggregate

Intrinsic

Value

 
                           

Outstanding at January 1, 2014

    4,622,505     $ 1.82            

     Granted

                     

     Exercised

    (1,161,570     1.36            

     Forfeited

    (5,000     30.00            
                           

Outstanding and exercisable at September 30, 2014

    3,455,935     $ 1.93   3.5   $ 859,029